Last reviewed · How we verify
NCT07406516: TENVOL
Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk
NA trial testing The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology. in Patellar Tendinitis in 60 participants. Not yet recruiting.
1 May 2029
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 1 May 2026 |
| Primary completion | 1 May 2029 |
| Estimated completion | 1 May 2029 |
| Sites | 1 location across France |
Drugs / interventions tested
- The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.
- The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology at 6 months and 12 months
Conditions studied
- Patellar Tendinitis — all drugs for Patellar Tendinitis →
- Jumper's Knee — all drugs for Jumper's Knee →
- Musculoskeletal Injuries — all drugs for Musculoskeletal Injuries →
- Knee Injuries — all drugs for Knee Injuries →
Sponsor
University Hospital, Montpellier
Who can join
Adults 18 to 45, male only, with Patellar Tendinitis or Jumper's Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research aims to identify and monitor specific kinematic markers associated with patellar tendinopathy in athletes at risk. Using a markerless motion capture system, vertical jump tests will be analyzed to detect early biomechanical changes in the knees, hips, trunk, and ankles. By comparing injured participants, the study seeks to improve early diagnosis and personalized prevention strategies for patellar tendinopathy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07406516
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07494942 — Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07406516 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 12 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07406516.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing